BioCentury
ARTICLE | Clinical News

Thrombopoietin: Started a Phase I trial

October 9, 1995 7:00 AM UTC

Genentech Inc. (GNE), South San Francisco Product: Thrombopoietin (TPO) Indication: Thrombocytopenia after chemotherapy Status: Started a Phase I trial ...